Investor
Avicella Capital
Avicella Capital invests in early-stage healthcare assets, medical devices, and health technology to improve patient outcomes and longevity.
Stage
Pre-seed–Seed
Sectors
2 sectors
Cheque
Not confirmed
Invests in
2 countries
Sectors
Invests in
About
This firm focuses on early-stage assets that increase healthcare quality and prolong human life. They invest in therapeutic assets and devices with established proof-of-concept and mechanism of action. The strategy involves funding advanced technologies for diagnosis and treatment precision to allow for early disease detection. Additionally, the firm seeks health tech companies that utilize real-time data and artificial intelligence to address evolving healthcare challenges and optimise clinical workflows.
How to approach
Submit an enquiry via the contact form on the company website.